Simulations Plus (NASDAQ:SLP – Get Free Report) was upgraded by investment analysts at Stephens to a “strong-buy” rating in a research note issued on Thursday,Zacks.com reports.
Several other brokerages have also commented on SLP. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, November 6th. StockNews.com downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. KeyCorp assumed coverage on shares of Simulations Plus in a research report on Monday, July 29th. They issued an “overweight” rating and a $47.00 price objective for the company. Finally, BTIG Research decreased their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Simulations Plus has a consensus rating of “Moderate Buy” and a consensus target price of $51.40.
View Our Latest Stock Report on SLP
Simulations Plus Trading Down 3.2 %
Simulations Plus (NASDAQ:SLP – Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company had revenue of $18.70 million during the quarter, compared to analysts’ expectations of $19.73 million. During the same period last year, the firm earned $0.18 EPS. The firm’s revenue for the quarter was up 19.9% on a year-over-year basis. On average, analysts predict that Simulations Plus will post 1.12 earnings per share for the current fiscal year.
Insider Transactions at Simulations Plus
In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction on Friday, November 1st. The stock was sold at an average price of $27.66, for a total value of $553,200.00. Following the sale, the director now directly owns 3,462,584 shares in the company, valued at approximately $95,775,073.44. This trade represents a 0.57 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In the last three months, insiders have sold 60,750 shares of company stock worth $1,905,655. 20.90% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Simulations Plus
A number of institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in Simulations Plus by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 1,135,105 shares of the technology company’s stock valued at $46,710,000 after buying an additional 12,636 shares during the last quarter. State Street Corp grew its position in Simulations Plus by 4.7% in the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company’s stock worth $20,503,000 after purchasing an additional 28,953 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Simulations Plus by 4.4% during the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after purchasing an additional 18,924 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Simulations Plus by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after buying an additional 37,992 shares during the last quarter. Finally, Tributary Capital Management LLC grew its position in Simulations Plus by 54.7% during the third quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after buying an additional 115,122 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Stories
- Five stocks we like better than Simulations Plus
- What Are Dividend Champions? How to Invest in the Champions
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Capture the Benefits of Dividend Increases
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Options Trading – Understanding Strike Price
- Time to Load Up on Home Builders?
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.